| Cell line name |
A2780-DX1 |
| Accession |
CVCL_4T95 |
| Resource Identification Initiative |
To cite this cell line use: A2780-DX1 (RRID:CVCL_4T95) |
| Comments |
Population: African American. Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin). Derived from site: In situ; Ovary; UBERON=UBERON_0000992. |
| Sequence variations |
- Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (from parent cell line).
- Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (from parent cell line).
|
| Disease |
Ovarian endometrioid adenocarcinoma (NCIt: C7979) Endometrioid carcinoma of ovary (ORDO: Orphanet_454723) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Hierarchy |
Parent: CVCL_0134 (A2780) Children:
|
| Sex of cell |
Female |
| Age at sampling |
Age unspecified |
| Category |
Cancer cell line |
| Publications | PubMed=2598402; DOI=10.1007/BF00692343 Moulay Abdellah Alaoui-Jamali, Ming-Biao Yin, Alessandra Mazzoni, Issam Bankusli, Youcef M. Rustum; Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933. Cancer Chemother. Pharmacol. 25:77-83(1989) PubMed=2243668; DOI=10.1159/000226878 Alessandra Mazzoni, Fabio Trave, Patrizia Russo, Angelo Nicolin, Youcef M. Rustum; Generation and characterization of a low-degree drug-resistant human tumor cell line. Oncology 47:488-494(1990) |
| Cross-references |
| Cell line databases/resources |
cancercelllines; CVCL_4T95
|
| Encyclopedic resources |
Wikidata; Q54606565
|
| Entry history |
| Entry creation | 22-Sep-2015 |
| Last entry update | 10-Apr-2025 |
| Version number | 13 |
|---|